Font Size: a A A
Keyword [Chronic Myelogenous Leukemia]
Result: 161 - 180 | Page: 9 of 10
161. The Role And Mechanism Of Exosomes In Imatinib Resistance Of Chronic Myelogenous Leukemia
162. One-step Discrimination Of BCR/ABLp210 Transcript Isoform With Fusion-triggered Rolling Circle Amplification
163. Resensitizing To Tyrosine Kinase Inhibitor By Inhibiting PFKFB3 In TKI Resistant Chronic Myelogenous Leukemia Cells
164. LncRNA Transcriptomics Analysis And Functional Study In Cml Multidrug-resistant Cells
165. The Effect Of Paeoniflorin On Reversing Multidrug Resistance Of Chronic Myelogenous Leukemia Adriamvcin-resistant K562/ADR Cells And Its Molecular Mechanism
166. Exploration Of NK Cells Function And Megakaryocytes-related Proteins In CML Patients With TKI-resistance
167. Effects Of Ros-autophagy Loop On Imatinib Resistance In Chronic Myeloid Leukemia
168. Comparison Of Clinical Effects And Adverse Reactions Between Domestic And Imported Imatinib In The Chronic Phase Of Chronic Myelogenous Leukemia
169. YTHDF2 Promotes The Growth Of Chronic Myelogenous Leukemia As An M6A Reader Protein
170. Prognostic Value Of BCR-ABL And Clinical Significance Of ABL Kinase Domain Mutation After TKIs
171. TRIB2 Knockdown As A Regulator Of Chemotherapy Resistance And Proliferation Via The ERK/STAT3 Signaling Pathway In Human Chronic Myelogenous Leukemia K562/ADM Cells
172. The Study Of TAL1 In IM-induced CML Cell Apoptosis And Erythroid Differentiation
173. SOS1 Regulates Imatinib-Sensitivity And –Resistance With BCR-ABL1-Independent And Its Molecular Mechanismin Chronic Myelogenous Leukemia(CLM)
174. Study On The Anti-tumor Activity And Mechanism Of Tanshinone ?A In Granulocytic Leukemia
175. The biomechanical basis of DNA breakage in chronic myelogenous leukemia
176. Altered mRNA metabolism in chronic myelogenous leukemia: Loss of microRNA-328 decoy activity is important for blastic transformation of leukemic progenitors
177. Immune restoration of patients with chronic myelogenous leukemia in complete cytogenetic remission
178. Folate status and risk of relapse following allogeneic hematopoietic cell transplant for chronic myelogenous leukemia
179. Regulation of Bcr-Abl signal transduction in the differentiation and survival of chronic myelogenous leukemia cells
180. Dissecting molecular mechanisms of leukemogenesis with a mouse chronic myelogenous leukemia model
  <<First  <Prev  Next>  Last>>  Jump to